ImaBiotech website in English


  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news

HD Target Engagement

Imabiotech offers a fast solution to assess the target engagement of your drugs using a label free Quantitative MALDI imaging technology click for more information.

With this new services, you can screen and select drug candidates based on the co-distribution of drugs with the targets.

Target Engagement Studies

  • Focused drug co-distribution with Targets (Receptor, protein, ligand) using MALDI Imaging Mass Spectrometry and other imaging techniques (IHC, H&E, PET or MRI imaging) in whole body or selected organs
  • Quantitative study of drug, metabolites and biomakers
  • Use of unique dedicated software (quantinetix)
  • High resolution: 20µm

Tissues samples

  • Every organs
  • Snap frozen tissues
  • FFPE tissues

Combined with

  • ImmunoHistoChemistry
  • Hematoxylin & Eosin staining
  • MRI or PET imaging